mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
0.001 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |